Dmitriy Minond Ph.D., is a Professor in the Barry and Judy Silverman College of Pharmacy Department of Pharmaceutical Sciences and Rumbaugh Goodwin Institute for Cancer Research. His research interests are drug and probe discovery in cancer and other diseases. His main contribution to the field is the discovery of non-zinc-binding inhibitors for multiple zinc metalloproteases that are currently used for translational and pre-clinical studies for various therapeutic indications. Dr. Minond authored more than 50 scientific articles and book chapters. Dr. Minond is an inventor on patents for drug discovery in cancer, Alzheimer’s disease, and rheumatoid arthritis. He also serves as a chair and a reviewer for NIH and DOD grant review panels and multiple scientific journals. Dr. Minond is a recipient of multiple state and federal grants.
CRDWC 2026
Oral Presentation